Header Logo

Connection

JASVINDER SINGH to United States

Back to Details
This is a "connection" page, showing publications JASVINDER SINGH has written about United States.
JASVINDER SINGH
Connection Strength
5.969
United States
  1. Barriers to and facilitators of sustaining a systemic lupus erythematosus (SLE) patient decision aid in regular rheumatology outpatient care in the USA. Rheumatology (Oxford). 2025 Jun 01; 64(6):3580-3586.
    View in: PubMed
    Score: 0.083
  2. Rural-urban disparities in hospitalisation for myocardial infarction in systemic lupus erythematosus in the USA. Lupus Sci Med. 2025 Apr 28; 12(1).
    View in: PubMed
    Score: 0.082
  3. Association of Patient Sex With Inpatient Mortality After Elective Primary Total Hip Arthroplasty for Osteoarthritis. J Clin Rheumatol. 2025 Jun 01; 31(4):134-141.
    View in: PubMed
    Score: 0.081
  4. Osteoarthritis Across Joint Sites in the Million Veteran Program Cohort: Insights From Electronic Health Records and Military Service History. J Rheumatol. 2025 Jan 01; 52(1):66-76.
    View in: PubMed
    Score: 0.080
  5. Women undergoing primary total hip arthroplasty (THA) for hip fracture have lower in-hospital mortality compared to men. Injury. 2024 Dec; 55(12):111970.
    View in: PubMed
    Score: 0.079
  6. Hospital and Patient Factors Associated With Length of Hospitalization in Patients Who Have Osteoarthritis Undergoing Primary Total Knee Arthroplasty: An Analysis of National Data. J Arthroplasty. 2025 Apr; 40(4):887-892.e2.
    View in: PubMed
    Score: 0.079
  7. Patient Perspectives on a Decision Aid for Systemic Lupus Erythematosus: Insights and Future Considerations. J Rheumatol. 2024 Aug 01; 51(8):798-803.
    View in: PubMed
    Score: 0.078
  8. Association between diabetes mellitus and total hip arthroplasty outcomes: an observational study using the US National Inpatient Sample. BMJ Open. 2024 07 22; 14(7):e085400.
    View in: PubMed
    Score: 0.078
  9. 2023 American College of Rheumatology and American Association of Hip and Knee Surgeons Clinical Practice Guideline for the Optimal Timing of Elective Hip or Knee Arthroplasty for Patients With Symptomatic Moderate-to-Severe Osteoarthritis or Advanced Symptomatic Osteonecrosis With Secondary Arthritis for Whom Nonoperative Therapy Is Ineffective. J Arthroplasty. 2023 11; 38(11):2193-2201.
    View in: PubMed
    Score: 0.073
  10. 2023 American College of Rheumatology and American Association of Hip and Knee Surgeons Clinical Practice Guideline for the Optimal Timing of Elective Hip or Knee Arthroplasty for Patients With Symptomatic Moderate-to-Severe Osteoarthritis or Advanced Symptomatic Osteonecrosis With Secondary Arthritis for Whom Nonoperative Therapy Is Ineffective. Arthritis Care Res (Hoboken). 2023 11; 75(11):2227-2238.
    View in: PubMed
    Score: 0.073
  11. 2023 American College of Rheumatology and American Association of Hip and Knee Surgeons Clinical Practice Guideline for the Optimal Timing of Elective Hip or Knee Arthroplasty for Patients With Symptomatic Moderate-to-Severe Osteoarthritis or Advanced Symptomatic Osteonecrosis With Secondary Arthritis for Whom Nonoperative Therapy Is Ineffective. Arthritis Rheumatol. 2023 11; 75(11):1877-1888.
    View in: PubMed
    Score: 0.073
  12. Association between the number of adopted implementation strategies and contextual determinants: a mixed-methods study. BMC Health Serv Res. 2022 Dec 13; 22(1):1518.
    View in: PubMed
    Score: 0.070
  13. 2022 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty. Arthritis Rheumatol. 2022 09; 74(9):1464-1473.
    View in: PubMed
    Score: 0.067
  14. 2022 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty. Arthritis Care Res (Hoboken). 2022 09; 74(9):1399-1408.
    View in: PubMed
    Score: 0.067
  15. 2022 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty. J Arthroplasty. 2022 09; 37(9):1676-1683.
    View in: PubMed
    Score: 0.067
  16. SToRytelliing to Improve Disease outcomes in Gout (STRIDE-GO) in African American veterans with gout: a trial study protocol. Trials. 2021 Dec 04; 22(1):879.
    View in: PubMed
    Score: 0.065
  17. Epidemiology of hospitalizations with cocaine use disorder: A 17-year U.S. national study. J Psychiatr Res. 2021 12; 144:32-36.
    View in: PubMed
    Score: 0.064
  18. Epidemiology of hospitalizations with amphetamine use disorder: A 17-year U.S. national cross-sectional study. Asian J Psychiatr. 2021 11; 65:102849.
    View in: PubMed
    Score: 0.064
  19. Epidemiology, Time Trends, and Outcomes of Serious Infections in Patients With Vasculitis: A Nineteen-Year National Study. Arthritis Care Res (Hoboken). 2021 10; 73(10):1544-1551.
    View in: PubMed
    Score: 0.064
  20. Recent health-related quality of life, but not change, predicted mortality and healthcare utilization. J Clin Epidemiol. 2021 12; 140:13-21.
    View in: PubMed
    Score: 0.064
  21. Time-trends in hospitalizations with cannabis use disorder: A 17-year U.S. national study. Subst Abus. 2022; 43(1):408-414.
    View in: PubMed
    Score: 0.063
  22. Management of Rheumatic Diseases During the COVID-19 Pandemic: A National Veterans Affairs Survey of Rheumatologists. Arthritis Care Res (Hoboken). 2021 07; 73(7):998-1003.
    View in: PubMed
    Score: 0.063
  23. Serious Infections in Patients With Gout in the US: A?National Study of Incidence, Time Trends, and Outcomes. Arthritis Care Res (Hoboken). 2021 06; 73(6):898-908.
    View in: PubMed
    Score: 0.063
  24. Time trends in hospitalizations with anxiolytic, sedative, or hypnotic drug use disorder: a 17-year U.S. national study. J Addict Dis. 2022 Jan-Mar; 40(1):4-11.
    View in: PubMed
    Score: 0.062
  25. Epidemiology of hospitalizations with hallucinogen use disorder: a 17-year U.S. National study. J Addict Dis. 2021 Oct-Dec; 39(4):545-549.
    View in: PubMed
    Score: 0.062
  26. Hospitalized Infections in Lupus: A Nationwide Study of Types of Infections, Time Trends, Health Care Utilization, and In-Hospital Mortality. Arthritis Rheumatol. 2021 04; 73(4):617-630.
    View in: PubMed
    Score: 0.062
  27. Factors associated with healthcare utilization and mortality in alcohol use disorder hospitalization. Drug Alcohol Depend. 2021 05 01; 222:108653.
    View in: PubMed
    Score: 0.061
  28. Declining in-hospital mortality gap between systemic lupus erythematosus (SLE) and non-SLE hospitalisations: a national study. Ann Rheum Dis. 2021 05; 80(5):672-675.
    View in: PubMed
    Score: 0.060
  29. Trends in Hospitalizations for Alcohol Use Disorder in the US From 1998 to 2016. JAMA Netw Open. 2020 09 01; 3(9):e2016580.
    View in: PubMed
    Score: 0.059
  30. Hospitalized Infections in People With Osteoarthritis: A National US Study. J Rheumatol. 2021 06; 48(6):933-939.
    View in: PubMed
    Score: 0.059
  31. Juvenile idiopathic arthritis is associated with higher healthcare utilization after total knee or hip replacement. Scand J Rheumatol. 2021 Jan; 50(1):34-39.
    View in: PubMed
    Score: 0.059
  32. Serious infections in people with systemic sclerosis: a national US study. Arthritis Res Ther. 2020 06 29; 22(1):163.
    View in: PubMed
    Score: 0.059
  33. Response to: 'Correspondence to "Hypersensitivity reactions with allopurinol and febuxostat: a study using the Medicare claims data' by Ma et al. Ann Rheum Dis. 2022 06; 81(6):e108.
    View in: PubMed
    Score: 0.059
  34. Response to: 'Confunding by indication and ethnicity difference? Comment on 'Hypersensitivity reactions with allopurinol and febuxostat: a study using the Medicare claims data'' by Hsu et al. Ann Rheum Dis. 2022 07; 81(7):e123.
    View in: PubMed
    Score: 0.059
  35. Serious infections in people with polymyalgia rheumatica (PMR) or giant cell arteritis (GCA): a time-trend national US study. Clin Rheumatol. 2020 Nov; 39(11):3427-3438.
    View in: PubMed
    Score: 0.058
  36. Spondyloarthritis is associated with higher healthcare utilization and complication rates after primary total knee or total hip arthroplasty. Clin Rheumatol. 2020 Aug; 39(8):2345-2353.
    View in: PubMed
    Score: 0.057
  37. National U.S. time-trends in opioid use disorder hospitalizations and associated healthcare utilization and mortality. PLoS One. 2020; 15(2):e0229174.
    View in: PubMed
    Score: 0.057
  38. Hypersensitivity reactions with allopurinol and febuxostat: a study using the Medicare claims data. Ann Rheum Dis. 2020 04; 79(4):529-535.
    View in: PubMed
    Score: 0.057
  39. Polymyositis has minimal effect on primary total knee or hip arthroplasty outcomes. Clin Rheumatol. 2020 Mar; 39(3):823-830.
    View in: PubMed
    Score: 0.057
  40. Socioeconomic status and healthcare access are associated with healthcare utilization after knee arthroplasty: A U.S. national cohort study. Joint Bone Spine. 2020 Mar; 87(2):157-162.
    View in: PubMed
    Score: 0.056
  41. Age, race, comorbidity, and insurance payer type are associated with outcomes after total ankle arthroplasty. Clin Rheumatol. 2020 Mar; 39(3):881-890.
    View in: PubMed
    Score: 0.056
  42. Association of Early Postoperative Pain Trajectories With Longer-term Pain Outcome After Primary Total Knee Arthroplasty. JAMA Netw Open. 2019 11 01; 2(11):e1915105.
    View in: PubMed
    Score: 0.056
  43. How Systemic Sclerosis Affects Healthcare Use and Complication Rates after Total Hip Arthroplasty. J Rheumatol. 2020 08 01; 47(8):1218-1223.
    View in: PubMed
    Score: 0.056
  44. Comparative effectiveness of allopurinol and febuxostat for the risk of atrial fibrillation in the elderly: a propensity-matched analysis of Medicare claims data. Eur Heart J. 2019 09 21; 40(36):3046-3054.
    View in: PubMed
    Score: 0.056
  45. Systemic sclerosis is associated with knee arthroplasty outcomes: a National US study. Clin Rheumatol. 2020 Jan; 39(1):85-92.
    View in: PubMed
    Score: 0.055
  46. Factors Influencing the Effectiveness of Allopurinol in Achieving and Sustaining Target Serum Urate in a US Veterans Affairs Gout Cohort. J Rheumatol. 2020 03; 47(3):449-460.
    View in: PubMed
    Score: 0.055
  47. Insurance Payer Type and Patient Income Are Associated with Outcomes after Total Shoulder Arthroplasty. J Rheumatol. 2020 04; 47(4):589-596.
    View in: PubMed
    Score: 0.054
  48. Lupus is associated with poorer outcomes after primary total hip arthroplasty. Lupus. 2019 Jun; 28(7):834-842.
    View in: PubMed
    Score: 0.054
  49. Individualized decision aid for diverse women with lupus nephritis (IDEA-WON): A randomized controlled trial. PLoS Med. 2019 05; 16(5):e1002800.
    View in: PubMed
    Score: 0.054
  50. Rates of Total Joint Replacement in the United States: Future Projections to 2020-2040 Using the National Inpatient Sample. J Rheumatol. 2019 09; 46(9):1134-1140.
    View in: PubMed
    Score: 0.054
  51. Gout and chronic pain in older adults: a Medicare claims study. Clin Rheumatol. 2019 Jul; 38(7):1953-1960.
    View in: PubMed
    Score: 0.054
  52. Gout is associated with a higher risk of chronic renal disease in older adults: a retrospective cohort study of U.S. Medicare population. BMC Nephrol. 2019 03 15; 20(1):93.
    View in: PubMed
    Score: 0.054
  53. The risk of Sjogren's syndrome in the older adults with gout: A medicare claims study. Joint Bone Spine. 2019 Oct; 86(5):615-619.
    View in: PubMed
    Score: 0.053
  54. Gout is associated with increased healthcare utilization after knee arthroplasty. Ann Rheum Dis. 2019 08; 78(8):1146-1148.
    View in: PubMed
    Score: 0.053
  55. Challenges of Practicing Rheumatology in a Government Setting: A County Hospital and Veterans Affairs Hospital Perspective. Rheum Dis Clin North Am. 2019 02; 45(1):39-51.
    View in: PubMed
    Score: 0.053
  56. Gout and healthcare utilization and complications after hip arthroplasty: a cohort study using the US National Inpatient Sample (NIS). Clin Rheumatol. 2019 Apr; 38(4):1213-1216.
    View in: PubMed
    Score: 0.053
  57. Gout and the risk of Parkinson's disease in older adults: a study of U.S. Medicare data. BMC Neurol. 2019 Jan 05; 19(1):4.
    View in: PubMed
    Score: 0.053
  58. Special Article: 2018 American College of Rheumatology/National Psoriasis Foundation Guideline for the Treatment of Psoriatic Arthritis. Arthritis Care Res (Hoboken). 2019 01; 71(1):2-29.
    View in: PubMed
    Score: 0.053
  59. Gout and dementia in the elderly: a cohort study of Medicare claims. BMC Geriatr. 2018 11 14; 18(1):281.
    View in: PubMed
    Score: 0.052
  60. Gout and the risk of incident depression in older adults. Psychiatry Res. 2018 12; 270:842-844.
    View in: PubMed
    Score: 0.052
  61. Gout and the Risk of Incident Obstructive Sleep Apnea in Adults 65 Years or Older: An Observational Study. J Clin Sleep Med. 2018 09 15; 14(9):1521-1527.
    View in: PubMed
    Score: 0.052
  62. Gout and hearing impairment in the elderly: a retrospective cohort study using the US Medicare claims data. BMJ Open. 2018 08 20; 8(8):e022854.
    View in: PubMed
    Score: 0.052
  63. Gout and Hypothyroidism in the Elderly: an Observational Cohort Study Using U.S. Medicare Claims Data. J Gen Intern Med. 2018 08; 33(8):1229-1231.
    View in: PubMed
    Score: 0.051
  64. Association of Gout With Uveitis in Older Individuals. JAMA Ophthalmol. 2018 07 01; 136(7):835-837.
    View in: PubMed
    Score: 0.051
  65. The association of gout with incident giant cell arteritis in older adults. Joint Bone Spine. 2019 03; 86(2):219-224.
    View in: PubMed
    Score: 0.051
  66. Gout and the risk of myocardial infarction in older adults: a study of Medicare recipients. Arthritis Res Ther. 2018 06 01; 20(1):109.
    View in: PubMed
    Score: 0.051
  67. Medicaid or Medicare insurance payer status and household income are associated with outcomes after primary total hip arthroplasty. Clin Rheumatol. 2018 Sep; 37(9):2489-2496.
    View in: PubMed
    Score: 0.051
  68. Allopurinol and the risk of incident peripheral arterial disease in the elderly: a US Medicare claims data study. Rheumatology (Oxford). 2018 03 01; 57(3):451-461.
    View in: PubMed
    Score: 0.050
  69. Septic Arthritis in Emergency Departments in the US: A National Study of Health Care Utilization and Time Trends. Arthritis Care Res (Hoboken). 2018 02; 70(2):320-326.
    View in: PubMed
    Score: 0.050
  70. Clinical Practice Guidelines: Incorporating Input From a Patient Panel. Arthritis Care Res (Hoboken). 2017 08; 69(8):1125-1130.
    View in: PubMed
    Score: 0.048
  71. Comparative effectiveness of allopurinol versus febuxostat for preventing incident renal disease in older adults: an analysis of Medicare claims data. Ann Rheum Dis. 2017 Oct; 76(10):1669-1678.
    View in: PubMed
    Score: 0.047
  72. Allopurinol and the risk of ventricular arrhythmias in the elderly: a study using US Medicare data. BMC Med. 2017 03 22; 15(1):59.
    View in: PubMed
    Score: 0.047
  73. Allopurinol use and the risk of acute cardiovascular events in patients with gout and diabetes. BMC Cardiovasc Disord. 2017 03 14; 17(1):76.
    View in: PubMed
    Score: 0.047
  74. Racial differences in health-related quality of life and functional ability in patients with gout. Rheumatology (Oxford). 2017 01; 56(1):103-112.
    View in: PubMed
    Score: 0.045
  75. Allopurinol and the risk of stroke in older adults receiving medicare. BMC Neurol. 2016 Sep 07; 16(1):164.
    View in: PubMed
    Score: 0.045
  76. Emergency Department and Inpatient Healthcare utilization due to Hypertension. BMC Health Serv Res. 2016 07 26; 16:303.
    View in: PubMed
    Score: 0.045
  77. Are allopurinol dose and duration of use nephroprotective in the elderly? A Medicare claims study of allopurinol use and incident renal failure. Ann Rheum Dis. 2017 Jan; 76(1):133-139.
    View in: PubMed
    Score: 0.044
  78. Allopurinol and the risk of atrial fibrillation in the elderly: a study using Medicare data. Ann Rheum Dis. 2017 Jan; 76(1):72-78.
    View in: PubMed
    Score: 0.044
  79. Time Trends, Predictors, and Outcome of Emergency Department Use for Gout: A Nationwide US Study. J Rheumatol. 2016 08; 43(8):1581-8.
    View in: PubMed
    Score: 0.044
  80. Gout-related inpatient utilization: a study of predictors of outcomes and time trends. Arthritis Res Ther. 2016 Mar 02; 18:57.
    View in: PubMed
    Score: 0.043
  81. Utilization due to chronic obstructive pulmonary disease and its predictors: a study using the U.S. National Emergency Department Sample (NEDS). Respir Res. 2016 Jan 06; 17:1.
    View in: PubMed
    Score: 0.043
  82. A Real-World Study of Switching From Allopurinol to Febuxostat in a Health Plan Database. J Clin Rheumatol. 2015 Dec; 21(8):411-8.
    View in: PubMed
    Score: 0.043
  83. Persisting Racial Disparities in Total Shoulder Arthroplasty Utilization and Outcomes. J Racial Ethn Health Disparities. 2016 06; 3(2):259-66.
    View in: PubMed
    Score: 0.042
  84. Comparative effectiveness of urate lowering with febuxostat versus allopurinol in gout: analyses from large U.S. managed care cohort. Arthritis Res Ther. 2015 May 12; 17:120.
    View in: PubMed
    Score: 0.041
  85. Does hospital volume predict outcomes and complications after total shoulder arthroplasty in the US? Arthritis Care Res (Hoboken). 2015 May; 67(6):885-90.
    View in: PubMed
    Score: 0.041
  86. Racial disparities in total ankle arthroplasty utilization and outcomes. Arthritis Res Ther. 2015 Mar 21; 17:70.
    View in: PubMed
    Score: 0.041
  87. Increasing obesity and comorbidity in patients undergoing primary total hip arthroplasty in the U.S.: a 13-year study of time trends. BMC Musculoskelet Disord. 2014 Dec 17; 15:441.
    View in: PubMed
    Score: 0.040
  88. Trends in and disparities for acute myocardial infarction: an analysis of Medicare claims data from 1992 to 2010. BMC Med. 2014 Oct 24; 12:190.
    View in: PubMed
    Score: 0.040
  89. Sex differences in characteristics, utilization, and outcomes of patient undergoing total elbow arthroplasty: a study of the US nationwide inpatient sample. Clin Rheumatol. 2016 Mar; 35(3):723-31.
    View in: PubMed
    Score: 0.040
  90. Time trends in total ankle arthroplasty in the USA: a study of the National Inpatient Sample. Clin Rheumatol. 2016 Jan; 35(1):239-45.
    View in: PubMed
    Score: 0.039
  91. Racial disparities in knee and hip total joint arthroplasty: an 18-year analysis of national Medicare data. Ann Rheum Dis. 2014 Dec; 73(12):2107-15.
    View in: PubMed
    Score: 0.037
  92. Cerebrovascular disease is associated with outcomes after total knee arthroplasty: a US total joint registry study. J Arthroplasty. 2014 Jan; 29(1):40-3.
    View in: PubMed
    Score: 0.036
  93. Income and patient-reported outcomes (PROs) after primary total knee arthroplasty. BMC Med. 2013 Mar 06; 11:62.
    View in: PubMed
    Score: 0.035
  94. Patient-level clinically meaningful improvements in activities of daily living and pain after total hip arthroplasty: data from a large US institutional registry. Rheumatology (Oxford). 2013 Jun; 52(6):1109-18.
    View in: PubMed
    Score: 0.035
  95. 2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis. Arthritis Care Res (Hoboken). 2012 May; 64(5):625-39.
    View in: PubMed
    Score: 0.033
  96. Summary of AHRQ's comparative effectiveness review of drug therapy for rheumatoid arthritis (RA) in adults--an update. J Manag Care Pharm. 2012 May; 18(4 Supp C):S1-18.
    View in: PubMed
    Score: 0.033
  97. A systematic review of validated methods for identifying orthopedic implant removal and revision using administrative data. Pharmacoepidemiol Drug Saf. 2012 Jan; 21 Suppl 1:265-73.
    View in: PubMed
    Score: 0.033
  98. Smoking as a risk factor for short-term outcomes following primary total hip and total knee replacement in veterans. Arthritis Care Res (Hoboken). 2011 Oct; 63(10):1365-74.
    View in: PubMed
    Score: 0.032
  99. Accuracy of VA databases for diagnoses of knee replacement and hip replacement. Osteoarthritis Cartilage. 2010 Dec; 18(12):1639-42.
    View in: PubMed
    Score: 0.030
  100. Health care utilization in patients with gout. Semin Arthritis Rheum. 2011 Jun; 40(6):501-11.
    View in: PubMed
    Score: 0.030
  101. A national survey of Veterans Affairs rheumatologists for relevance of quality of care indicators for gout management. Arthritis Care Res (Hoboken). 2010 Sep; 62(9):1306-11.
    View in: PubMed
    Score: 0.030
  102. Assessment of the methodologic quality of medical and surgical clinical trials in patients with arthroplasty. J Rheumatol. 2009 Dec; 36(12):2642-54.
    View in: PubMed
    Score: 0.028
  103. Discordance between self-report of physician diagnosis and administrative database diagnosis of arthritis and its predictors. J Rheumatol. 2009 Sep; 36(9):2000-8.
    View in: PubMed
    Score: 0.028
  104. Spondyloarthritis is associated with poor function and physical health-related quality of life. J Rheumatol. 2009 May; 36(5):1012-20.
    View in: PubMed
    Score: 0.027
  105. Health care utilization in patients with spondyloarthropathies. Rheumatology (Oxford). 2009 Mar; 48(3):272-6.
    View in: PubMed
    Score: 0.027
  106. Gout is associated with more comorbidities, poorer health-related quality of life and higher healthcare utilisation in US veterans. Ann Rheum Dis. 2008 Sep; 67(9):1310-6.
    View in: PubMed
    Score: 0.025
  107. Effect of health-related quality of life on women and men's Veterans Affairs (VA) health care utilization and mortality. J Gen Intern Med. 2007 Sep; 22(9):1260-7.
    View in: PubMed
    Score: 0.024
  108. Health-related quality of life predicts future health care utilization and mortality in veterans with self-reported physician-diagnosed arthritis: the veterans arthritis quality of life study. Semin Arthritis Rheum. 2005 Apr; 34(5):755-65.
    View in: PubMed
    Score: 0.020
  109. Health-related quality of life profiles of adults with arthritis and/or fibromyalgia: a cross-sectional study. Qual Life Res. 2025 Feb; 34(2):523-534.
    View in: PubMed
    Score: 0.020
  110. Long-Term Mortality Following SARS-CoV-2 Infection in Rural Versus Urban Dwellers With Autoimmune or Inflammatory Rheumatic Disease: A Retrospective Cohort Analysis From the National COVID Cohort Collaborative. Arthritis Care Res (Hoboken). 2025 Jan; 77(1):143-155.
    View in: PubMed
    Score: 0.020
  111. Hearing Loss Prevalence, Years Lived With Disability, and Hearing Aid Use in the United States From 1990 to 2019: Findings From the Global Burden of Disease Study. Ear Hear. 2024 Jan-Feb 01; 45(1):257-267.
    View in: PubMed
    Score: 0.018
  112. 2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis. Arthritis Rheumatol. 2021 07; 73(7):1108-1123.
    View in: PubMed
    Score: 0.016
  113. The Burden of Skin and Subcutaneous Diseases in the United States From 1990 to 2017. JAMA Dermatol. 2020 08 01; 156(8):874-881.
    View in: PubMed
    Score: 0.015
  114. 2020 American College of Rheumatology Guideline for the Management of Gout. Arthritis Rheumatol. 2020 06; 72(6):879-895.
    View in: PubMed
    Score: 0.015
  115. Gout is associated with an increased risk for incident heart failure among older adults: the REasons for Geographic And Racial Differences in Stroke (REGARDS) cohort study. Arthritis Res Ther. 2020 04 16; 22(1):86.
    View in: PubMed
    Score: 0.014
  116. Recommendations for the management of rheumatoid arthritis in the Eastern Mediterranean region: an adolopment of the 2015 American College of Rheumatology guidelines. Clin Rheumatol. 2018 Nov; 37(11):2947-2959.
    View in: PubMed
    Score: 0.013
  117. Trends in opioid and nonsteroidal anti-inflammatory use and adverse events. Am J Manag Care. 2018 03 01; 24(3):e61-e72.
    View in: PubMed
    Score: 0.012
  118. Trends in Joint Replacement Surgery in Patients with Rheumatoid Arthritis. J Rheumatol. 2018 02; 45(2):158-164.
    View in: PubMed
    Score: 0.012
  119. 2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups. Ann Rheum Dis. 2017 12; 76(12):1955-1964.
    View in: PubMed
    Score: 0.012
  120. 2017 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Adult and Juvenile Idiopathic Inflammatory Myopathies and Their Major Subgroups. Arthritis Rheumatol. 2017 12; 69(12):2271-2282.
    View in: PubMed
    Score: 0.012
  121. 2017 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty. Arthritis Care Res (Hoboken). 2017 08; 69(8):1111-1124.
    View in: PubMed
    Score: 0.012
  122. 2017 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty. Arthritis Rheumatol. 2017 08; 69(8):1538-1551.
    View in: PubMed
    Score: 0.012
  123. 2017 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty. J Arthroplasty. 2017 09; 32(9):2628-2638.
    View in: PubMed
    Score: 0.012
  124. Development of the American College of Rheumatology's Rheumatoid Arthritis Electronic Clinical Quality Measures. Arthritis Care Res (Hoboken). 2016 11; 68(11):1579-1590.
    View in: PubMed
    Score: 0.011
  125. Performance of Gout Impact Scale in a longitudinal observational study of patients with gout. Rheumatology (Oxford). 2016 06; 55(6):982-90.
    View in: PubMed
    Score: 0.011
  126. Comparative effects of biologics on cardiovascular risk among older patients with rheumatoid arthritis. Ann Rheum Dis. 2016 Oct; 75(10):1813-8.
    View in: PubMed
    Score: 0.011
  127. Validation of administrative codes for calcium pyrophosphate deposition: a Veterans Administration study. J Clin Rheumatol. 2015 Jun; 21(4):189-92.
    View in: PubMed
    Score: 0.010
  128. Association of hyperlipidaemia, inflammation and serological status and coronary heart disease among patients with rheumatoid arthritis: data from the National Veterans Health Administration. Ann Rheum Dis. 2016 Feb; 75(2):341-7.
    View in: PubMed
    Score: 0.010
  129. Risk of hospitalized bacterial infections associated with biologic treatment among US veterans with rheumatoid arthritis. Arthritis Care Res (Hoboken). 2014 Jul; 66(7):990-7.
    View in: PubMed
    Score: 0.010
  130. The state of US health, 1990-2010: burden of diseases, injuries, and risk factors. JAMA. 2013 Aug 14; 310(6):591-608.
    View in: PubMed
    Score: 0.009
  131. Total knee arthroplasty volume, utilization, and outcomes among Medicare beneficiaries, 1991-2010. JAMA. 2012 Sep 26; 308(12):1227-36.
    View in: PubMed
    Score: 0.009
  132. Improving the efficiency and effectiveness of pragmatic clinical trials in older adults in the United States. Contemp Clin Trials. 2012 Nov; 33(6):1211-6.
    View in: PubMed
    Score: 0.008
  133. The attributable risk of smoking on surgical complications. Ann Surg. 2011 Dec; 254(6):914-20.
    View in: PubMed
    Score: 0.008
  134. Derivation and preliminary validation of an administrative claims-based algorithm for the effectiveness of medications for rheumatoid arthritis. Arthritis Res Ther. 2011; 13(5):R155.
    View in: PubMed
    Score: 0.008
  135. Gout in the Hmong in the United States. J Clin Rheumatol. 2010 Sep; 16(6):262-6.
    View in: PubMed
    Score: 0.007
  136. Perceptions of disease and health-related quality of life among patients with gout. Rheumatology (Oxford). 2009 May; 48(5):582-6.
    View in: PubMed
    Score: 0.007
  137. Leflunomide use during the first 33 months after food and drug administration approval: experience with a national cohort of 3,325 patients. Arthritis Rheum. 2003 Dec 15; 49(6):745-51.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.